期刊文献+

PARP-1抑制剂对骨肉瘤细胞增殖及凋亡的影响 被引量:4

Inhibitory effects of PARP-1 inhibitor on growth of human osteosarcoma cells.
下载PDF
导出
摘要 目的探讨PARP-1抑制剂3-aminobenzamide(3-AB)对骨肉瘤U2OS细胞增殖及凋亡的影响。方法常规培养骨肉瘤U2OS细胞,采用CCK-8法检测U2OS细胞的增殖和流式细胞术检测细胞凋亡,并用caspase-3活性测定试剂盒检测caspase-3活性和Western-blot技术检测Bcl-2、Bax的表达。结果 3-AB能抑制骨肉瘤细胞的增殖,且与剂量和时间呈相关性,流式细胞术检测结果显示3-AB能促进骨肉瘤细胞的凋亡,且呈时间相关性,3-AB刺激早期caspase-3活性增高,Western-blot显示3-AB刺激后随时间延长Bax的表达量逐渐升高,而Bcl-2的表达量则轻度升高后降低。结论 PARP-1抑制剂3-AB能抑制骨肉瘤细胞的增殖,促进其凋亡,这为PARP-1作为骨肉瘤治疗的新靶点提供了初步实验依据。 Objective To investigate the influence of PARP-1 inhibitor(3-aminobenzamide,3-AB) on the proliferation and apoptosis of osteosarcoma cells.Methods The U2OS cells were routinely cultured.CCK-8 was used to analyze cell proliferation,apoptosis was assessed by flow cytometry,the caspase-3 activity was measured by caspase-3 colorimetric assay kit,and the expression of Bcl-2 and Bax was detected by using Western blot.Results 3-AB suppressed the proliferation of osteosarcoma cells in a dose-and time-dependent manner.It also increased apoptosis ratio of osteosarcoma cells,after treated with 3-AB,the caspase-3 activity in osteosarcoma cells was elevated,the expression of Bax increased,and the expression of Bcl-2 first slightly increased and then decreased.Conclusion 3-AB suppresses cell growth and induces apoptosis in human osteosarcoma cells.Our study provided a preliminary evidence by using PARP-1 as a new target for osteosarcoma treatment.
出处 《骨科》 CAS 2011年第1期13-16,共4页 ORTHOPAEDICS
关键词 骨肉瘤 细胞增殖 细胞凋亡 Osteosarcoma Cell proliferation Apoptosis
  • 相关文献

参考文献14

  • 1黄胜辉,黄志勇.PARP-1:一个肿瘤治疗的新靶点[J].世界华人消化杂志,2006,14(9):841-847. 被引量:11
  • 2Schreiber V,Dantzer F,Ame J C,et al.Poly(ADP-ribose):novel functions for an old molecule. Nature Reviews Molecular Cell Biology . 2006
  • 3Lindahl T.Instability and decay of the primary structure of DNA. Nature . 1993
  • 4Cregan SP,Dawson VL,Slack RS.Role of AIF in caspasedependent and caspase-independent cell death. Oncegene . 2004
  • 5Fisher D E.Apoptosis in cancer therapy: crossing the threshold. Cell . 1994
  • 6Albert JM,Cao C,Kim KW, et al.Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models. Clinical Cancer Research . 2007
  • 7CK Donawho,Y Luo,TD Penning,JL Bauch,JJ Bouska,VD Bontcheva-Diaz,BF Cox,TL DeWeese,LE Dillehay,DC Ferguson,NS Ghoreishi-Haack,DR Grimm,R Guan,EK Han,RR Holley-Shanks,B Hristov,KB Idler,K Jarvis,EF Johnson,LR Kleinberg,V Klinghofer,LM Lasko,X Liu,KC Marsh.ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models. Clinical Cancer Research . 2007
  • 8Bryant HE,Schultz N,Thomas HD,et al.Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase. Nature . 2005
  • 9Farmer H,McCabe N,Lord CJ,et al.Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature . 2005
  • 10Martin-Oliva D,Aguilar-Quesada R,O‘valle F, et al.Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Research . 2006

二级参考文献45

  • 1Rouleau M, Aubin RA, Poirier GG. Poly(ADP-ribosyl)ated chromatin domains: access granted. J Cell Sci 2004; 117: 815-825
  • 2Haince JF, Rouleau M, Hendzel MJ, Masson JY, Poirier GG. Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy. Trends Mol Med 2005; 11: 456-463
  • 3Leppard JB, Dong Z, Mackey ZB, Tomkinson AE. Physical and functional interaction between DNA ligase IIIalpha and poly (ADP-Ribose) polymerase 1 in DNA single-strand break repair. Mol Cell Biol 2003; 23: 5919-5927
  • 4El-Khamisy SF, Masutani M, Suzuki H, Caldecott KW. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res 2003; 31: 5526-5533
  • 5Prasad R, Lavrik OI, Kim SJ, Kedar P, Yang XP, Vande Berg BJ, Wilson SH. DNA polymerase beta -mediated long patch base excision repair. Poly(ADP-ribose)polymerase-1 stimulates strand displacement DNA synthesis. J Biol Chem 2001; 276: 32411-32414
  • 6Pleschke JM, Kleczkowska HE, Strohm M, Althaus FR. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 2000; 275: 40974-40980
  • 7Susse S, Scholz CJ, Burkle A, Wiesmuller L. Poly(ADP-ribose) polymerase (PARP-1) and p53 independently function in regulating double-strand break repair in primate cells. Nucleic Acids Res 2004; 32: 669-680
  • 8de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, Walztinger C, Chambon P, de Murcia G. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 1997; 94: 7303-7307
  • 9Schultz N, Lopez E, Saleh-Gohari N, Helleday T. Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination. Nucleic Acids Res 2003; 31: 4959-4964
  • 10Dominguez I, Mateos S, Cortes F. Yield of SCEs and translocations produced by 3 aminobenzamide in cultured Chinese hamster cells. Mutat Res 2000; 448: 29-34

共引文献10

同被引文献60

  • 1周欣,黄志勇,陈孝平,黄胜辉.PARP-1抑制剂PJ34对人肝癌细胞株HepG2的抑制作用[J].世界华人消化杂志,2007,15(16):1806-1809. 被引量:7
  • 2Gibson BA, Kraus WL. New insights into the molecular and cel- lular functions of poly (ADP-ribose) and PARPs. Nat Rev Mol Cell Biol, 2012, 13: 411--424.
  • 3Sodhi RK, Singh N, Jaggi AS. Poly (ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications. Vascul Pharmacol, 2010, 53: 77-87.
  • 4Veres B, Radnai B, Gallyas F Jr, et al. Regulation of kinase cascades and transcription factors by a poly (ADP-ribose) poly- merase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide- induced inflammation in mice. J Pharmacol Exp Ther, 2004, 310 : 247-255.
  • 5Kummar S, Chen A, Parchment RE, et al. Advances in using PARP inhibitors to treat cancer. BMC Med, 2012, 10: 25.
  • 6Abd Elmageed ZY, Naura AS, Errami Y, et al. The poly ( ADP- ribose) polymerases (PARPs) : new roles in intracellular trans- port. Cell Signal, 2012, 24: 1-8.
  • 7Plummer R. Poly (ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer?. Breast Cancer Res, 2011, 13: 218-223.
  • 8Calabrese CR, Batey MA, Thomas HD, et al. Identification of potent nontoxic poly (ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies. Clin Cancer Res, 2003, 9: 2711-2718.
  • 9Barreto-Andrade JC, Efimova EV, Mauceri H J, et al. Response of human prostate cancer cells and tumors to combining PARP in- hibition with ionizing radiation. Mol Cancer Ther, 2011, 10: 1185-1193.
  • 10Farmer H, McCabe N, Lord CJ, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature, 2005, 434: 917-921.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部